Functionally, PSME2 is capable of promoting the presentation of tumor-derived antigens on MHC class I molecules 8, thereby facilitating, for example, the presentation of the TRP2 360-368 epitope in melanoma to enable the activation of cytotoxic T lymphocytes (CTLs) reactive to this antigenic moiety 9. This evidence concerns the gene PSME2 and melanoma.